WebThe primary endpoint was mean change from baseline in Fugl-Meyer Motor Scale (FMMS) score which was used to measure changes in motor impairment at six months after treatment with SB623 cells. The STEMTRA trial enrolled 61 patients from 13 surgical and 18 assessment sites in the U.S., Japan and Ukraine. http://www.physioblasts.org/f/public/1354395651_1_FT0_fugl-meyer-1332679_fm-le-english.pdf
Determining minimally clinically important …
WebBackground: This study aimed to establish the minimal clinically important difference (MCID) for the Fugl-Meyer Motor Scale (FMMS) and the Disability Rating Scale … WebThe efficacy of fluoxetine on the NIHSS and FMMS is likely to take time to emerge and is expected to be transient. ... [mean difference (MD)=-0.67, 95% confidence interval (CI) (-1.19 to -0.15)] and the Fugl-Meyer Motor Scale (FMMS) score [MD=17.36, 95% CI (12.12-22.61)] at the 3-month follow up. However, the NIHSS score showed no significant ... dictionary of the meaning of
Fugl-Meyer Assessment of Sensorimotor Function After Stroke
WebFugl-Meyer Assessment (FMA) scale is an index to assess the sensorimotor impairment in individuals who have had stroke. [1] This scale was first proposed by Axel Fugl-Meyer and his colleagues as a standardized assessment test for post-stroke recovery in their paper titled The post-stroke hemiplegic patient: A method for evaluation of physical ... WebMar 22, 2024 · Conclusion: In post-stroke treatment, fluoxetine did not improve participants' mRS and NIHSS but improved FMMS and BI. This difference could result from heterogeneities between the trials: different treatment duration, clinical scales sensitivity, patient age, delay of inclusion, and severity of the deficit. WebMar 11, 2015 · FMA-UE PROTOCOL Rehabilitation Medicine, University of Gothenburg Approved by Fugl-Meyer AR 2010 3 Updated 2015-03-11 TOTAL A-D (max 66) H. … city criminal lawyers